Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
2023
Primeros objetivos basados en la ciencia para la naturaleza (tierra y agua dulce)
La publicación de los primeros Objetivos para la Naturaleza Basados en la Ciencia (SBTN) supone un avance significativo para que…
An investors guide to nature and biodiversity risks and impacts
The MSCI paper stresses that despite the challenges posed by data and models, management frameworks exist, regulatory pressure grows, models…
State of the world’s migratory species
This report represents an important step forward in the development of a work plan for the conservation of migratory species.…